Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

GOP, Dem senators remain divided over Medicaid after Trump’s ‘big, beautiful bill’ vote

by admin June 30, 2025
June 30, 2025
GOP, Dem senators remain divided over Medicaid after Trump’s ‘big, beautiful bill’ vote

Senate Republicans and Democrats remain divided on the Medicaid issue hours after President Donald Trump’s ‘big, beautiful bill’ passed a key Senate vote Saturday night.

Sen. Jim Banks, R-Ind., and Sen. Chris Coons, D-Del., both appeared on ‘Fox News Sunday’ to discuss Trump’s legislation in the wake of the 51-49 vote.

Banks argued that the Medicaid reforms would only affect certain people.

‘The Medicaid reforms would affect able-bodied Americans, those who are sitting at home who can work, who don’t work, who don’t have a sick kid or a sick mom, they shouldn’t receive Medicaid without working,’ he said. ‘And on top of that, the bill would take Medicaid away from illegal immigrants.’

Coons conceded there are states that are using their state funding to provide healthcare ‘for people who are undocumented,’ though argued that Trump’s $900 billion cuts to the program ‘are not about throwing people off of Medicaid who are not here legally.’

‘They are about imposing more and more requirements on the beneficiaries of Medicaid,’ the Democrat said.

Banks argued that taxes for everyday Americans will go up if the bill doesn’t get passed.

‘If we don’t pass this bill, everyone’s taxes on average will go up $2,000 a household, and that’s not fair to the regular Americans who work hard every day,’ he said.

Lingering concerns in both chambers about Medicaid — specifically the Medicaid provider tax rate and the effect of direct payments to states — energy tax credits, the state and local tax (SALT) deduction and others proved to be pain points that threatened the bill’s survival.

Coons, however, said that Americans who don’t believe the Democrats’ standpoint should listen to Sen. Tom Tillis, R-N.C., who, along with Sen. Rand Paul, R-Ky., voted against the bill.

‘Don’t believe me. Listen to Senator Tom Tillis,’ Coons said. ‘He’s been saying loudly this bill is a bad deal for the middle class. It’ll raise healthcare costs and throw millions off of needed health care.’

On Sunday morning, Trump slammed both Tillis and Paul on social media. 

Hours later, Tillis announced he would not seek reelection.

Following the vote, Minority Leader Chuck Schumer, D-N.Y., demanded that the text of the behemoth bill be read aloud before debates begin. After 14 hours, Senate clerks were still about 120 pages short of finishing reading aloud the 940-page text.

Once the reading is finished, the two parties will each get about 10 hours to debate on the bill. 

The timeline puts a likely Senate vote-a-rama on the bill in the early morning hours of Monday. A final passage vote could happen between late morning and late Monday night.

Fox News Digital’s Alex Miller and Fox News’ Tyler Olson contributed to this report.

This post appeared first on FOX NEWS

previous post
Rep. Steube slams Senate parliamentarian for gutting Trump’s legislative agenda
next post
Thom Tillis announces retirement from Senate after clash with Trump

Related Posts

State Department approves sale of $1.4B worth of...

May 14, 2025

Warren explains her applause to Trump’s ‘Pocahontas’ jab...

March 7, 2025

Trump has his own deadline, ‘no allegiance to...

April 25, 2025

Third top Pentagon aide Colin Carroll on administrative...

April 17, 2025

SCOOP: House to hold hearings next week on...

March 25, 2025

Secretary of State Rubio hails release of US...

January 27, 2025

Iran foreign minister vows nuclear enrichment will continue...

May 19, 2025

‘Presidential incapacity’: Senate Republican seeks paper trail of...

June 27, 2025

Supreme Court hands Ed Sheeran legal win in...

June 17, 2025

US airstrikes leave a mark on Iran’s nuclear...

June 25, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved